Stress del reticolo endoplasmatico nella malattia renale cronica. Nuovi approcci clinico translazionali dal laboratorio al letto del paziente

Carlo Alberto Ricciardi*, Luigi Gnudi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The identification of new biomarkers/pharmacological targets for chronic kidney disease (CKD) is required for the development of more effective therapies. Several studies in vitro and in vivo have shown the importance of the endoplasmic reticulum (ER) (cellular organelle devolved to protein biosynthesis and maturation, and cellular detoxification processes) in the pathophysiology of CKD. Hence, the synthesis and development of novel drugs against the different ER intracellular pathways is crucial in order to slow down the development and progression of renal diseases. This review aims to dissect the role of the different ER branches (PERK, IRE1α, ATF6) and their function in CKD, providing potential insights for the development of new treatments.

Original languageItalian
Pages (from-to)9-18
Number of pages10
JournalGiornale Italiano di Nefrologia
Volume36
Issue number6
Publication statusPublished - 1 Nov 2019

Keywords

  • chronic kidney disease
  • endoplasmic reticulum
  • reticulon
  • unfolded protein response

Cite this